{"id":928667,"date":"2026-01-20T13:26:48","date_gmt":"2026-01-20T18:26:48","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/"},"modified":"2026-01-20T13:26:48","modified_gmt":"2026-01-20T18:26:48","slug":"gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/","title":{"rendered":"GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million"},"content":{"rendered":"<p>        <!--.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nGrant funding awarded to support lupus-focused community programs across the United States<\/p>\n<\/li>\n<\/ul>\n<p>PHILADELPHIA&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nGSK plc (LSE\/NYSE: GSK) has announced the recipients of the Linked by Lupus: Optimal Care Initiative grant, awarding nearly $1 million to support national, state, and local non-profit organizations working to improve the lives of people impacted by lupus, including systemic lupus erythematosus (SLE) and lupus nephritis (LN).<\/p>\n<p>\nGSK previously sought proposals for community-driven initiatives aimed at improving earlier diagnosis and recognition of lupus signs and symptoms; enhancing awareness of and access to evidence-based treatment options; and\/or advancing communication between patients and providers regarding lupus.<\/p>\n<p>\n\u201cWe\u2019re proud to support these organizations that are deeply embedded in their communities and uniquely positioned to drive meaningful change,\u201d <b>Court Horncastle, Senior Vice President at GSK, said<\/b>. \u201cTheir work is essential to improving the lupus journey, from diagnosis to treatment to ongoing care, and we\u2019re honored to help bring their visions to life.\u201d<\/p>\n<p>\nLaunched in <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fus.gsk.com%2Fen-us%2Fmedia%2Fpress-releases%2Fgsk-announces-the-linked-by-lupus-optimal-care-initiative-to-help-support-individuals-with-lupus-in-the-us%2F&amp;esheet=54398107&amp;newsitemid=20260115842061&amp;lan=en-US&amp;anchor=June+2025&amp;index=1&amp;md5=80c5300356d4c9fb86b5cd54e8829e3f\">June 2025<\/a>, the Linked by Lupus: Optimal Care Initiative is part of GSK\u2019s ongoing commitment to improving outcomes for people living with lupus. These efforts align with the initiative\u2019s mission to foster a more connected, informed, and supported lupus community. The selected organizations include 13 grantees from across the country, chosen for their innovative, community-led programs designed to improve earlier diagnosis, enhance awareness of and access to evidence-based treatment, and advance communication between patients and providers.<\/p>\n<p>\nThe 2025 Linked by Lupus grant recipients include:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nAutoimmune Association, Clinton Township, MI<\/p>\n<\/li>\n<li>\nAmerican Kidney Fund, Rockville, MD<\/p>\n<\/li>\n<li>\nAME Zion Health Ministry, Rochester, NY<\/p>\n<\/li>\n<li>\nKaleidoscope Fighting Lupus, Marylhurst, OR (<i>funded for 2026<\/i>)<\/p>\n<\/li>\n<li>\nLatinaStrong Foundation, Peoria, Arizona<\/p>\n<\/li>\n<li>\nLooms For Lupus, Baldwin Park, CA<\/p>\n<\/li>\n<li>\nLupus Foundation of America Texas Gulf Coast Chapter, Houston, TX<\/p>\n<\/li>\n<li>\nLupus Foundation of America, Greater Ohio Chapter, Brecksville, OH<\/p>\n<\/li>\n<li>\nLupus Foundation of America, Wisconsin Chapter, Milwaukee, WI<\/p>\n<\/li>\n<li>\nLupus LA, Los Angeles, CA<\/p>\n<\/li>\n<li>\nMichigan Lupus Foundation, Traverse City, MI<\/p>\n<\/li>\n<li>\nNational Kidney Foundation, New York, NY<\/p>\n<\/li>\n<li>\nWe Are ILL, USA<\/p>\n<\/li>\n<\/ul>\n<p><b>Anne Marie Blacketer, CFRE, CEO of Lupus Texas Gulf Coast<\/b>, an independent, locally based chapter of the Lupus Foundation of America, takes her lead from the community. Blacketer said, \u201cWe listened closely as members shared their need for greater education and awareness about lupus, including how to access the high-quality healthcare they deserve. From diagnostic testing and physicians who truly understand the disease to learning about and obtaining impactful treatments\u2014these are the resources and support we work to provide to individuals and their health partners.\u201d<\/p>\n<p>\nAs this work moves forward, GSK remains committed to supporting initiatives that strengthen and uplift lupus communities nationwide. These investments represent only one step in a long-term effort to advance meaningful change, expand access to resources, and empower those affected by lupus.<\/p>\n<p>\nMore information about future funding opportunities is available <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gsk.com%2Fen-gb%2Fresponsibility%2Fgrants-and-donations%2F&amp;esheet=54398107&amp;newsitemid=20260115842061&amp;lan=en-US&amp;anchor=here&amp;index=2&amp;md5=d8420e72744f4e9e77b35d39c4fa9113\">here<\/a>.<\/p>\n<p><b>About GSK<br \/>\n<br \/><\/b>GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.gsk.com&amp;esheet=54398107&amp;newsitemid=20260115842061&amp;lan=en-US&amp;anchor=gsk.com&amp;index=3&amp;md5=ac2ef995491980205ba4934fcbe21c6c\">gsk.com<\/a>.<\/p>\n<p><b>Cautionary statement regarding forward-looking statements<br \/>\n<br \/><\/b>GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in the \u201cRisk Factors\u201d section in GSK\u2019s Annual Report on Form 20-F for 2024, and GSK\u2019s Q3 Results for 2025.<\/p>\n<p><b>Registered in England &amp; Wales:<br \/>\n<br \/><\/b>No. 3888792<\/p>\n<p><b>Registered Office:<br \/>\n<br \/><\/b>79 New Oxford Street<br \/>\n<br \/>London<br \/>\n<br \/>WC1A 1DG<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260115842061r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260115842061\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260115842061\/en\/<\/a><\/span><\/p>\n<p><b>GSK inquiries<\/p>\n<p><\/b>Media<br \/>\n<br \/>Kathleen Quinn, +1 202 603 5003 (Washington DC)<br \/>\n<br \/>Lyndsay Meyer, +1 202 302 4595 (Washington DC)<\/p>\n<p>Investor Relations:<br \/>\n<br \/>Jeff McLaughlin, +1 215 751 7002 (Philadelphia)<br \/>\n<br \/>Frannie DeFranco, +1 215 751 3126 (Philadelphia)<\/p>\n<p><b>KEYWORDS:<\/b> Pennsylvania Europe United States United Kingdom North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260115842061\/en\/2693910\/3\/GSK_Signal_Full_Colour_RGB_PNG_%281%29.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million Grant funding awarded to support lupus-focused community programs across the United States PHILADELPHIA&#8211;(BUSINESS WIRE)&#8211; GSK plc (LSE\/NYSE: GSK) has announced the recipients of the Linked by Lupus: Optimal Care Initiative grant, awarding nearly $1 million to support national, state, and local non-profit organizations working to improve the lives of people impacted by lupus, including systemic lupus erythematosus (SLE) and lupus nephritis (LN). GSK previously sought proposals for community-driven initiatives aimed at improving earlier diagnosis and recognition of lupus signs and symptoms; enhancing awareness of and access to evidence-based treatment options; and\/or advancing communication between patients and providers regarding lupus. \u201cWe\u2019re proud to support these organizations that &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-928667","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million Grant funding awarded to support lupus-focused community programs across the United States PHILADELPHIA&#8211;(BUSINESS WIRE)&#8211; GSK plc (LSE\/NYSE: GSK) has announced the recipients of the Linked by Lupus: Optimal Care Initiative grant, awarding nearly $1 million to support national, state, and local non-profit organizations working to improve the lives of people impacted by lupus, including systemic lupus erythematosus (SLE) and lupus nephritis (LN). GSK previously sought proposals for community-driven initiatives aimed at improving earlier diagnosis and recognition of lupus signs and symptoms; enhancing awareness of and access to evidence-based treatment options; and\/or advancing communication between patients and providers regarding lupus. \u201cWe\u2019re proud to support these organizations that &hellip; Continue reading &quot;GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-20T18:26:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260115842061r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million\",\"datePublished\":\"2026-01-20T18:26:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\\\/\"},\"wordCount\":649,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260115842061r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\\\/\",\"name\":\"GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260115842061r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-01-20T18:26:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260115842061r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260115842061r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/","og_locale":"en_US","og_type":"article","og_title":"GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million - Market Newsdesk","og_description":"GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million Grant funding awarded to support lupus-focused community programs across the United States PHILADELPHIA&#8211;(BUSINESS WIRE)&#8211; GSK plc (LSE\/NYSE: GSK) has announced the recipients of the Linked by Lupus: Optimal Care Initiative grant, awarding nearly $1 million to support national, state, and local non-profit organizations working to improve the lives of people impacted by lupus, including systemic lupus erythematosus (SLE) and lupus nephritis (LN). GSK previously sought proposals for community-driven initiatives aimed at improving earlier diagnosis and recognition of lupus signs and symptoms; enhancing awareness of and access to evidence-based treatment options; and\/or advancing communication between patients and providers regarding lupus. \u201cWe\u2019re proud to support these organizations that &hellip; Continue reading \"GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-20T18:26:48+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260115842061r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million","datePublished":"2026-01-20T18:26:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/"},"wordCount":649,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260115842061r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/","name":"GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260115842061r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-01-20T18:26:48+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260115842061r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260115842061r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gsk-announces-recipients-of-linked-by-lupus-optimal-care-initiative-grants-nearing-1-million\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/928667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=928667"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/928667\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=928667"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=928667"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=928667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}